SELEGILINE IN THE TREATMENT OF DAILY FLUCTUATIONS IN DISABILITY OF PARKINSONIAN-PATIENTS WITH LONG-TERM LEVODOPA TREATMENT

被引：1

作者：

HEINONEN, EH ^{[1
]}

RINNE, UK ^{[1
]}

TUOMINEN, J ^{[1
]}

机构：

[1] UNIV TURKU, DEPT NEUROL, SF-20500 TURKU 50, FINLAND

来源：

ACTA NEUROLOGICA SCANDINAVICA | 1989年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：113 / 118

页数：6

共 20 条

[1]

BIRMAYER W, 1977, LANCET, V1, P349

[2]

BRODERSEN P, 1985, ACTA NEUROL SCAND, V71, P494

[3]

DUVOISIN RC, 1971, MONOAMINES NOYAUX GR, P313

[4] DEPRENYL IN PARKINSON DISEASE [J].

EISLER, T ;

TERAVAINEN, H ;

NELSON, R ;

KREBS, H ;

WEISE, V ;

LAKE, CR ;

EBERT, MH ;

WHETZEL, N ;

MURPHY, DL ;

KOPIN, IJ ;

CALNE, DB .

NEUROLOGY, 1981, 31 (01) :19-23

[5] DEPRENYL IN THE TREATMENT OF SYMPTOM FLUCTUATIONS IN ADVANCED PARKINSONS-DISEASE [J].

GOLBE, LI ;

LIEBERMAN, AN ;

MUENTER, MD ;

AHLSKOG, JE ;

GOPINATHAN, G ;

NEOPHYTIDES, AN ;

FOO, SH ;

DUVOISIN, RC .

CLINICAL NEUROPHARMACOLOGY, 1988, 11 (01) :45-55

[6]

HEINONEN EH, 1989, ACTA NEUROL SCAND, V80, P103

[7] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[8] POSSIBLE MECHANISMS OF ACTION OF (-)DEPRENYL IN PARKINSONS-DISEASE [J].

KNOLL, J .

JOURNAL OF NEURAL TRANSMISSION, 1978, 43 (3-4) :177-198

[9]

LIEBERMAN AN, 1984, NEW YORK STATE J MED, V84, P13

[10] DEPRENYL (SELEGILINE) COMBINED WITH LEVODOPA AND A DECARBOXYLASE INHIBITOR IN THE TREATMENT OF PARKINSONS-DISEASE [J].

PRESTHUS, J ;

HAJBA, A .

ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 :127-133

← 1 2 →